BRIEF published on 08/27/2024 at 13:05, 1 year 5 months ago Pharnext begins liquidation proceedings Creditors Liquidation Paris Commercial Court Pharnext Suspension Of Listing
BRIEF published on 08/27/2024 at 13:05, 1 year 5 months ago Pharnext entame une procédure de liquidation judiciaire Liquidation Judiciaire Tribunal De Commerce De Paris Suspension De Cotation Pharnext Créditeurs
PRESS RELEASE published on 08/27/2024 at 13:00, 1 year 5 months ago Ouverture d'une procédure de liquidation judiciaire Pharnext SCA, société biopharmaceutique en liquidation judiciaire après procédure de conciliation. Suspension de la cotation des actions Biopharmaceutique Liquidation Judiciaire Suspension Cotation Pharnext Procédure Conciliation
BRIEF published on 07/04/2024 at 20:05, 1 year 7 months ago Pharnext announces the termination of the financing contract granted by Néovacs Investors Termination Funding Pharnext Néovacs
BRIEF published on 07/04/2024 at 20:05, 1 year 7 months ago Pharnext annonce la résiliation du contrat de financement accordé par Néovacs Financement Investisseurs Pharnext Résiliation Néovacs
PRESS RELEASE published on 07/04/2024 at 20:00, 1 year 7 months ago Pharnext annonce la résiliation du contrat de financement accordé par Néovacs Pharnext annonce la résiliation anticipée du contrat de financement avec Néovacs suite à des cas de défaut. La société sollicite Global Tech Opportunities 13 pour son soutien Financement Pharnext Résiliation Néovacs Global Tech Opportunities
BRIEF published on 06/18/2024 at 18:35, 1 year 8 months ago Pharnext annonce la prorogation de la procédure de conciliation jusqu'au 15 juillet 2024 Pharnext Procédure De Conciliation CMT1A PXT3003 Tasly
BRIEF published on 06/18/2024 at 18:35, 1 year 8 months ago Pharnext announces the extension of the conciliation procedure until July 15, 2024 Pharnext Conciliation Procedure CMT1A PXT3003 Tasly
PRESS RELEASE published on 06/18/2024 at 18:30, 1 year 8 months ago Pharnext annonce la prorogation de la procédure de conciliation jusqu'au 15 juillet 2024 Pharnext annonce la prorogation de la procédure de conciliation jusqu'au 15 juillet 2024 pour poursuivre l'étude clinique de Phase III de PXT3003. Les résultats seront communiqués prochainement Conciliation Étude Clinique Pharnext PXT3003 Maladie Neurodégénérative
BRIEF published on 05/07/2024 at 19:15, 1 year 9 months ago Adjustment of the nominal value at Pharnext Biopharmaceutical Capital Reduction Pharnext Nominal Value Neurodegenerative Diseases
Published on 02/18/2026 at 15:15, 3 hours 30 minutes ago Host of "The Schaftlein Report" on Patriot.TV Delivers Urgent Warning to Trump: 2026 Midterm Course Correction Needed Now
Published on 02/18/2026 at 15:00, 3 hours 45 minutes ago Jaguar Health Announces a Special One-time Stock Dividend
Published on 02/18/2026 at 14:25, 4 hours 20 minutes ago Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular
Published on 02/18/2026 at 14:00, 4 hours 45 minutes ago Revolve Achieves Key Interconnection Milestone On 130 MW "El 24 Wind Project" In Mexico
Published on 02/18/2026 at 14:00, 4 hours 45 minutes ago Datametrex Receives $1M Order from Fortune 500 Client
Published on 02/18/2026 at 18:21, 23 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/18/2026 at 18:00, 45 minutes ago E-PANGO : Décision du Tribunal administratif de Paris en date du 16 février 2026
Published on 02/18/2026 at 17:58, 47 minutes ago 2CRSi SA: 2CRSi initiates, within the ÆTHER Infrastructure consortium, an exclusive negotiation for the establishment of a strategic industrial site dedicated to AI Gigafactories
Published on 02/18/2026 at 17:58, 47 minutes ago 2CRSi SA: 2CRSi initie, au sein du consortium ÆTHER Infrastructure, une négociation exclusive pour l’implantation d’un site industriel stratégique dédié aux AI Gigafactories
Published on 02/18/2026 at 15:50, 2 hours 55 minutes ago CGTN: Private economy: A key actor in advancing China's economic priorities in 2026 and beyond
Published on 02/18/2026 at 18:00, 45 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 janvier 2026
Published on 02/18/2026 at 18:00, 45 minutes ago Outstanding Shares and Voting Rights Statement at 31 January 2026
Published on 02/18/2026 at 13:45, 5 hours ago NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède
